Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01855490 · ClinicalTrials.gov registry record · Phase 1

Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

A Phase 1 study of Type 1 Diabetes, sponsored by Yale University.

Completed
Registry status
Phase 1
Development phase
17
Enrollment target
1
Study location

NCT01855490 is a Phase 1 study of Type 1 Diabetes that has completed, run by Yale University. The registered enrollment target is 17 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01855490, a Phase 1 study of Type 1 Diabetes, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 1
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The study is designed as an open labeled pilot trial to analyze the acute responses of glucose, GLP-1, GIP, insulin secretory,and glucagon to a mixed meal tolerance test (MMTT) or intravenous glucose tolerance tests (IVGTT) with and without pretreatment with Exenatide (Byetta) 5 mcg sc. The investigators will also test the effects of Exenatide on gastric emptying during the MMTT.

Conditions Studied

Type 1 Diabetes

Interventions

  • DRUG Exenatide

Study Locations (1)

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2012-01
Est. Completion 2013-10
Phase Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01855490

The ClinicalTrials.gov registry entry for NCT01855490 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Exenatide is the first listed.

NCT01855490 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01855490 about?

NCT01855490 is a clinical study titled "Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes". The study is designed as an open labeled pilot trial to analyze the acute responses of glucose, GLP-1, GIP, insulin secretory,and glucagon to a mixed meal tolerance test (MMTT) or intravenous glucose tolerance tests (IVGTT) with and without pretreatment with Exenatide (Byetta) 5 mcg sc. The investi...

What is the current status of trial NCT01855490?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2012-01. Estimated completion is 2013-10.

What conditions does trial NCT01855490 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT01855490?

The interventions under investigation include: Exenatide (DRUG).

Who is sponsoring clinical trial NCT01855490?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01855490 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.